Form D Explorer

Source evidence

Myris Therapeutics, Inc. · 0001924725-26-000004

D filed Oct. 14, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
SHARPSBURG
street1
307 23RD ST. EXT
street2
SUITE 150
zipCode
15215
entityName
Myris Therapeutics, Inc.
entityType
Corporation
stateOrCountry
PA
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold500000number500000/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount4500000number4500000/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count4number4/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 52543b971b05822bde38cccb81495985b441686810754b272536ac98bb201ebb. This proves extraction identity, not the accuracy of the filer's claims.